Clinician Recommendation Increases Patient Willingness to Use Behavioral Pain Strategies

Integrating Behavioral Health into Multimodal Cancer Pain Management

Managing chronic pain in complex patient populations requires a multimodal approach that balances clinical efficacy with the long-term risks of pharmacological therapy, as long-term opioid use is associated with increased risks of opioid use disorder and overdose [1, 2]. Clinical guidelines for common conditions like low back pain now prioritize nonpharmacological strategies, including cognitive behavioral therapy (a psychological intervention targeting maladaptive thought patterns) and multidisciplinary rehabilitation, to improve functional outcomes and reduce global disability [3]. The efficacy of these strategies often depends on patient motivation, where intrinsic motivation (the internal drive to engage in a behavior for its own sake) serves as a stronger predictor of long-term adherence than external pressures [4]. Furthermore, a systematic review of 55 studies demonstrated that positive patient experiences are consistently associated with higher treatment adherence and better objectively measured health outcomes [5]. Despite these established benefits, the systematic integration of behavioral health into oncology remains inconsistent. A recent cross-sectional analysis examines the specific barriers to and facilitators of behavioral health engagement among oncology outpatients, offering insights into how clinicians can better incorporate these tools into daily cancer care.

Quantifying the Awareness and Utilization Gap

The researchers conducted a cross-sectional survey involving 455 oncology outpatients with chronic pain at a comprehensive cancer center to evaluate the integration of behavioral health interventions. These interventions, which encompass psychological or lifestyle-based strategies used alongside traditional medical care, are evidence-based components of multimodal pain management. Despite their established efficacy in reducing pain interference and improving quality of life, the findings reveal that these strategies remain severely underused in oncology populations. This discrepancy suggests that the current standard of care may not be fully leveraging nonpharmacological modalities to address the complex pain needs of patients with cancer.

The data quantified a significant deficit in both patient knowledge and clinical application. Only 17.6% of the participants were aware of behavioral health strategies for pain management, and an even smaller fraction, only 4.0% of participants, reported current use of such strategies. These results indicate that behavioral health remains underrecognized and underused as a treatment modality for pain in oncology settings. For practicing oncologists and pain specialists, these specific gaps highlight a critical need for improved patient education and more robust clinical pathways to bridge the divide between evidence-based behavioral theory and daily clinical practice.

Predictors of Patient Engagement and Receptivity

To identify the specific drivers of patient interest in nonpharmacological pain management, the researchers utilized multivariable logistic and linear regression analyses (statistical methods used to isolate the independent effect of multiple variables on a single outcome). These models allowed the team to examine the associations between patient receptivity and a wide array of demographic and clinical factors. The demographic variables included in the analysis were age, sex, ethnicity, and insurance status. On the clinical side, the researchers evaluated how a history of psychiatric diagnosis, current pain severity, and the use of opioid medications influenced a patient's likelihood of adopting behavioral strategies. By controlling for these variables, the study aimed to pinpoint which oncology outpatients are most likely to respond to behavioral health referrals in a busy clinical setting.

The survey items specifically measured awareness and current use of behavioral health strategies, alongside a patient's willingness to try these interventions if recommended by their physician. These data points were aggregated into a composite engagement score, a metric designed to reflect the overall receptivity of a patient to behavioral health support. The analysis revealed that certain subgroups demonstrated significantly higher levels of interest in these modalities. Specifically, engagement with behavioral health was greater among women and among patients with a psychiatric diagnosis in their health history. These findings indicate that while overall utilization remains low, patients with prior exposure to mental health care or specific demographic profiles may be more prepared to incorporate behavioral health into their multimodal pain treatment plans, allowing clinicians to target their initial referral efforts toward the most receptive populations.

The Clinical Leverage of Provider Endorsement

While current utilization of behavioral health strategies remains low among oncology outpatients, the study identifies a significant latent interest that clinicians can activate. Specifically, 34.3% of participants indicated a willingness to try behavioral health interventions if recommended by a provider. This finding suggests that the primary barrier to adoption may not be patient resistance, but rather a lack of clinical direction. Patients expressed a clear openness to incorporating these strategies into their pain management regimens, particularly when the suggestion originated from their treating clinician.

The statistical analysis confirms that the physician's voice is the most influential factor in patient decision-making regarding nonpharmacological care. Among those willing to try behavioral health, provider recommendation was the strongest motivator, yielding an odds ratio of 2.53 (P < .001). This odds ratio (a statistical measure indicating that patients are more than two and a half times as likely to consider behavioral health support when it is explicitly endorsed by their medical team) underscores the immense clinical leverage physicians hold.

These findings highlight a critical opportunity for clinicians to bridge the existing access gap through targeted education and proactive engagement. Because patients demonstrate increased receptivity when behavioral health is endorsed by clinicians, the integration of these services into standard oncology care depends heavily on the provider's initiative. By actively recommending behavioral health as a standard component of pain management, physicians can effectively translate patient openness into active participation, ultimately improving the long-term management of chronic cancer pain.

References

1. Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016. MMWR Recommendations and Reports. 2016. doi:10.15585/mmwr.rr6501e1

2. Dowell D, Ragan K, Jones CM, Baldwin G, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain—United States, 2022. MMWR Recommendations and Reports. 2022. doi:10.15585/mmwr.rr7103a1

3. Chou R, Deyo R, Friedly J, et al. Nonpharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline. Annals of Internal Medicine. 2017. doi:10.7326/M16-2459

4. Teixeira PJ, Carraça EV, Markland D, Silva MN, Ryan RM. Exercise, physical activity, and self-determination theory: A systematic review. International Journal of Behavioral Nutrition and Physical Activity. 2012. doi:10.1186/1479-5868-9-78

5. Doyle C, Lennox L, Bell D. A systematic review of evidence on the links between patient experience and clinical safety and effectiveness. BMJ Open. 2013. doi:10.1136/bmjopen-2012-001570